Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_assertion type Assertion NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_head.
- NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_assertion wasGeneratedBy ECO_0000203 NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_provenance.
- NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_assertion wasDerivedFrom befree-20140225 NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_provenance.
- NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_assertion SIO_000772 21293001 NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_provenance.
- NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_assertion evidence source_evidence_literature NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_provenance.
- NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_provenance.